Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
   
Ask the Experts About

Choosing Your MedsChoosing Your Meds
           
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  
  • Email Email
  • Glossary Glossary


pep after 72 hours
Nov 23, 2012

I had insertive vaginal intercourse with a commercial sex worker in Philipines , without condom. I saw a doctor on day 3 after contact, who prescribed me tablet Atripla for 30 days. Unfortunately it took me a day to get hold of these pills. So my question is whteher starting PEP after 72 hours useless? Most studies and websites recommend to start it within 72 hours. So I have been taking it for a week now. Please tell me should I continue or am I just wasting medicine on myself?

Response from Dr. Young

Hello,

PEP is only effective if started withint 72 hours of the exposure. I would not have recommended starting in your situation, though getting screened for other sexually transmitted infections would be a good idea.

At this point, I'd probably stop.

Be well, BY



Previous
TB / AIDS diagnosis
Next
Please explain why Hiv+ off meds and healthier than when on

  
  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS


 
Advertisement



Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement